sb 202190 has been researched along with Arteriosclerosis in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Q | 1 |
| Zeng, X | 1 |
| Guo, J | 1 |
| Wang, X | 1 |
1 other study available for sb 202190 and Arteriosclerosis
| Article | Year |
|---|---|
Effects of homocysteine on murine splenic B lymphocyte proliferation and its signal transduction mechanism.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Arteriosclerosis; B-Lymphocytes; Catalase; Cell Di | 2001 |